Serial monitoring of N-terminal B-type natriuretic peptide (NT-proBNP) in patients with type 2 diabetes (T2D) and ischemic heart disease may be useful for identifying patients at highest risk for heart failure (HF), a recent study suggests. NT-proBNP was measured at baseline and 6 months. Cardiovascular (CV) death or hospitalization for HF was the primary end point. Researchers found:
- A graded relationship between increasing baseline and 6-month NT-proBNP concentration and the incidence of major CV events was observed.
- After adjusting for potential confounders, NT-proBNP at baseline was independently associated with the development of major CV events, especially hospitalization for HF.
- Patients with persistently high NT-proBNP or developed high NT-proBNP at 6 months were at a significantly higher risk for CV death/HF than those in whom NT-proBNP remained low at both time points.
- Treatment with a DPP-4 inhibitor did not meaningfully alter NT-proBNP concentrations.
Jarolim P, White WB, Cannon CP, Gao Q, Morrow DA. Serial measurement of natriuretic peptides and cardiovascular outcomes in patients with type 2 diabetes mellitus in the EXAMINE Trial. [Published online ahead of print May 30, 2018]. Diabetes Care. doi:10.2337/dc18-0109.
This Week's Must Reads
Androgen Deprivation Therapy & Risk of Depression, Cancer; ePub 2019 Feb 12; Deka, Rose, et al
QOL in Patients with Low-Risk PC Treated with HRT, JAMA Oncol; ePub 2019 Feb 14; Bruner, et al
Hospital Competition & Prostate Cancer Outcomes, Cancer; ePub 2019 Feb 1; Aggarwal, et al
Insurance Status & Stage of Prostate Ca Diagnosis, Cancer Epidemiol; 2019 Apr; Ramirez, Morano, et al
Agent Orange Exposure & Prostate Ca Outcomes, J Urol; ePub 2019 Jan 8; Etheridge, et al
Must Reads in Cardiology
AHA Statement: Accurate Measurement of BP, Hypertension; ePub 2019 Mar 4; Muntner, et al
Is Adding Aspirin to Warfarin Therapy Beneficial? , JAMA Intern Med; ePub 2019 Mar 4; Schaefer, et al
Psychosocial Stress & CV Health in Older Women, Circulation; ePub 2019 Feb 28; Burroughs-Peña, et al
AHA Statement: CV Risk Reduction in Pediatrics, Circulation; ePub 2019 Feb 25; de Ferranti, et al
Sedentary Behaviors & CVD Risk in Older Women, Circulation; 2019 Feb 19; Bellettiere, et al